Clinical Trial Supplies Market Growth Report 2030 by Key Players, Trends, Share, Segmentation
The global clinical trial supplies market was valued at approximately USD 2.58 billion in 2023 and is forecasted to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. This growth is attributed to the increasing globalization of clinical trials and a rise in the number of biologics and biosimilar drugs being tested. The biopharmaceutical industry is also experiencing greater adoption of supply chain management systems aimed at improving operational efficiency and managing the pressures of high R&D costs. Supplies for clinical trials make up a substantial portion of total R&D spending, and these efficiencies are expected to propel market expansion in the coming years. In particular, the growing prevalence of biologics and temperature-sensitive drugs in clinical trials highlights the need for effective supply management.
Currently, the market is in a medium growth stage, and its expansion rate is accelerating. A defining feature of the clinical trial supplies market is its high level of innovation, as advancements in trial equipment, including cutting-edge imaging systems, monitoring tools, and diagnostic devices, are enhancing trial efficiency. This trend in innovation is driving greater demand for clinical trial supplies.
The market has also seen a moderate level of merger and acquisition (M&A) activity among leading companies. Many companies seek to provide comprehensive solutions for trial sponsors by acquiring specialized firms or expanding their service portfolios. With clinical trials taking place on a global scale, companies are extending their geographic reach to conduct trials across diverse regions, which enhances their market positioning.
The clinical trial supplies market operates under stringent regulations, enforced by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to protect participant safety and rights. This regulatory environment encourages companies to establish a presence in multiple regions to meet the varying requirements. Expanding regionally also helps companies streamline operations and optimize resources to address regulatory compliance and logistical needs in different countries.
Gather more insights about the market drivers, restrains and growth of the Clinical Trial Supplies Market
Regional Insights:
North America Clinical Trial Supplies Market Trends
In 2023, North America held the largest market share, representing approximately 55.49% of the global clinical trial supplies market. This region conducts the highest volume of clinical trials worldwide, which significantly drives demand for trial supplies. Additionally, North America is home to many leading companies in this industry, along with high levels of technological penetration, which contribute to its market dominance.
United States
In the United States, the clinical trial supplies market is projected to grow at a substantial rate over the coming years. The presence of major contract research organizations (CROs), such as Quintiles, Covance, and PAREXEL International Corporation, further bolsters the market’s growth. However, there is a growing trend of shifting clinical trial sites outside the U.S. due to rising R&D costs and patient recruitment expenses. This shift is increasing the demand for cost-effective clinical supplies, thereby boosting market growth in emerging economies.
Asia Pacific Clinical Trial Supplies Market Trends
Asia Pacific is expected to be one of the fastest-growing regions in the clinical trial supplies market due to significant growth in clinical research. Key drivers for this regional expansion include lower per-patient costs and a diverse patient pool, which enhances recruitment efficiency. These factors make Asia Pacific an attractive region for clinical trials, contributing to the global market’s growth.
China
China, in particular, presents substantial growth opportunities for clinical trial supply companies due to its large, diverse patient population and expanding pharmaceutical sector. However, logistics and supply chain challenges in the country have deterred some biopharmaceutical companies from conducting trials there. China accounts for over 27% of global clinical trials as of 2023 and has shown strong growth over the past five years. To address these logistical challenges and capitalize on the market potential, companies like Catalent Pharma Solutions are entering the Chinese market, which is expected to further drive growth in the country’s clinical trial supplies sector.
Browse through Grand View Research's Category Medical Devices Industry Research Reports.
- The global 3D ultrasound market size was estimated at USD 3.73 billion in 2024 and is projected to grow at a CAGR of 7.8% from 2025 to 2030.
- The global lancets market size was valued at USD 5.90 billion in 2024 and is projected to grow at a CAGR of 7.7% from 2025 to 2030.
Key Companies & Market Share Insights
Leading companies in the clinical trial supplies market are adopting inorganic growth strategies, such as mergers, acquisitions, and partnerships, to strengthen their market positions. For example, in March 2023, Calyx, a provider of eClinical regulatory services, introduced Calyx Supply, a forecasting service designed to predict clinical trial supply needs through simulation and statistical design. Similarly, in April 2021, Catalent expanded its clinical supply services capabilities at its Philadelphia facility to support clients working on cell and gene therapies.
These strategic expansions and innovations underscore the competitive landscape of the clinical trial supplies market. By investing in enhanced capabilities and broadening their service offerings, key players are positioning themselves to meet the growing demands of a global clinical trial landscape characterized by a diverse range of drug types, regulatory requirements, and logistical challenges.
Key Clinical Trial Supplies Companies
- Almac Group
- Biocair
- Catalent Inc.
- KLIFO
- Movianto
- PCI Pharma Services
- Sharp Services, LLC
- Thermo Fischer Scientific Inc.
- Marken
- PAREXEL International Corporation
Order a free sample PDF of the Clinical Trial Supplies Market Intelligence Study, published by Grand View Research.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- IT, Cloud, Software and Technology
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian